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Taurine, 2-aminoethanesulfonic acid (H2NCH2CH2 SO3H), is a sulfonic acid analogue of 13-alanine that is present in all tissues of the body. In addition to skeletal muscles (75% of the body store), the heart also contains high concentrations of taurine: 5.6 (humans)-28 (rats) mM/kg wet weight (1) . The compound possesses iso tropic effects (2-4), a variety of electrophysiological effects such as modifications of the Ca 2+ current (5, 6) and antiarrhythmic actions (7 10). However, reports on tau rine actions on the cardiac Na+ current (INa) including Vmax studies are controversial: little direct (11), depressant (4, 12, 13), activating (3), or diverse (8, 14) actions (c.f. Table 4) .
Species-related variations in the tissue content of taurine and in the biosynthesis pathways (1) suggested that electrophysiological actions of this compound differ among species. Herein, we assessed whether taurine could influence INa in guinea pig ventricular cells and, if so, what kinds of kinetic parameters of the Na+ channel are the targets for the actions. The experimental findings suggest that taurine-induced changes in the surface charge and the number of movable charges in the moieties of channel proteins are involved in its depressant action on the Na+ channel.
MATERIALS AND METHODS

Experimental procedures
The heart was dissected out from guinea pigs (Seiwa, Fukuoka), which were under deep anesthesia from ure thane (600 mg/kg). The heart was quickly mounted in a Langendorff apparatus for the coronary perfusion. The method of obtaining single ventricular myocytes using both collagenase and pronase was essentially the same as described elsewhere (15). The animal experiments were performed in accordance with the Guideline for Animal Experiment (Yamaguchi University, School of Medicine).
Glass pipette electrodes were fabricated in a two-step Solutions and liquid junction potential The standard bath solution for v-c had the following composition: 80 mM NaCI, 80 mM sucrose, 20 mM TEA Cl, 10 mM HEPES, 10 mM glucose, 5 mM CsCI, 5 mM 4 aminopyridine, 3.0 mM CoC12 and 2.5 mM MgC12i (pH 7.4). The ionic composition of the bath solution for the current-clamp (c-c) study was: 140 mM NaCI, 5.4 mM KCI, 1.0 mM MgC12i 1.5 mM CaC12 and 10.0 mM HEPES (pH 7.4). A 0.5-ml bath chamber attached to the stage of an inverted microscope was continuously super fused at a rate of 1-2 ml/min. The bath temperature was controlled by a Peltier-effect unit at 16-17 C for v-c or at 26-27'C for c-c. The change in osmolality of the bath solution after taurine addition was corrected by removal of an equimolar amount of sucrose.
The composition of the internal solution for v-c was: 130 mM Cs-aspartate, 11 mM EGTA, 1.0 mM CaC12, 10.0 mM HEPES, 2.0 mM MgC12i 5 mM ATP-Na2 and 5 mM glucose (pH 7.0). For the c-c study, the Cs ion was replaced by equimolar K ion. The free Ca 21 concentra tion in the pipette solutions was estimated to be 3 x 10-9 M. The liquid junction potential (VI) between the bath and pipette solutions was determined independently, as suming a negligible Vli for 3 M KCI. The voltage values reported herein were all corrected for the Vl; of 15 mV. The passive membrane properties were carefully check ed prior to the experiments (17). In brief, the membrane capacitance (Cm) was determined either from time in tegration (51 dt) of the capacitive spike for 10-mV step pulses or from the current in response to ramp pulses (dV/dt=0.5 V/sec). The average of the Cm values so ob tained was 99 pF (n=53). The falling phase of the capacitative transients before compensation (upon 10-mV step pulses) was approximated by a single exponential function. The RS value was obtained from the time con stant (r) of the exponential fit, which is given by Cm x Rs. When nystatin was used, the average of the RS values was 8.3 MQ before RS compensations (n=53). In each experi ment, RS was usually compensated by 60-70%. After A/D conversions current signals were digitally trimmed by means of the P/4 method. Based on such Cm and RS values, the settling time (to 90% level) after each volt age step was calculated to be 200-1700 psec. In deter mining the activation time constants (Tm), INa data points within the settling time were not used. The residual INa points after deletion according to this criterion numbered in the teens (at + 30 mV) up to a few hundred (at -40 mV). Also, data were not used from experiments in which the voltage error at RS exceeded 3 mV. 
RESULTS
Maximum rate of rise (Vmax) of action potential Exposure of myocytes to taurine (10 mM) was followed by changes in AP parameters (5) . The rate of rise (Vmax) of APs underwent a slight (0 to -11 %) depression after taurine addition (Fig. 1 ). On average, the Vmax was 185±4.8 in the control and 176.4±4.7 V/sec in the taurine-treated group (n = 34), coinciding with the Vmax of 95.2±0.8010 of the control (P<0.01, paired t-test). Although Vmax has been suggested to be non-linearly related to INa (19), such minor but significant reductions of Vmax suggested taurine actions on INa. (Table IA) . The taurine-induced reductions of INa reached a saturated level ( 14% to -15°7o) at the concentration of 10 mM, so that the extent of the INa reduction was comparable for 10, 20 or 50 mM taurine. Hence, kinetic studies were carried out using 10 mM tau rine.
Concentration-effect relation
Taurine action on I-V parameters Table lB shows the changes in I-V parameters induced by taurine. In the control period, the maximal currents, magnitude of which were 400 2000 pA (ca. 8 pA/pF, on average), were seen at step voltages near 15 mV. After exposure to 10 mM taurine, neither the reversal potential (V1eV) nor the potential at which currents reached the peak (Vp) was affected. The only parameter affected by taurine was the channel conductance (gNa).
Also, we observed taurine-related increases in the delay time between the pulse onset and the start of current flow. A similar increased delay after taurine addition was reported earlier (14). However, we did not examine the 'delay in onset' , because a delay of variable lengths was already present even in the absence of taurine mainly due to the large membrane capacitance and the uncompensat ed fraction of RS. Activation kinetics gNa V,n relation: In the model for analyzing data, the Na+ current (INa) is described by the following equations:
where m and h are the activation and inactivation parameters, respectively, and GNa denotes the limiting (maximum) conductance. The Na+ conductance (gNa) was calculated according to eq. (1). Figure 3A shows the results of the gNa analyses carried out on the same data as presented in Fig. 2 . The gNa exhibited sigmoidal relations against the voltage. Such voltage-dependence of gNa was quantified by fitting the gNa data to the Boltzmann equa tion:
The figure and Table 2A show Vhalf and S and Table 1B shows the Peak gNa. In the presence of taurine, while the peak conductance (Peak gNa) was reduced, values of the half activation voltage (Vhalf) and slope factor (S) remained unchanged. In the presence of taurine, the slope factor (S) was slightly increased (P<0.05, paired t-test), whereas the Vhalf remained unchanged.
Hence, the change in the m. kinetics by taurine was minor in extent.
Time constant of activation: To determine the time constant of activation (rm) in a depolarized potential range (on-kinetics), the single pulse protocol was used (inset in Fig. 4A ; also, see Fig. 9 of Ref. 18. In the model, gating parameters, m and h, in eq. (2) are expressed respectively by: 
In the present experimental condition in which the resid ual (uncompensated) fraction of Cm was considerable in size, we failed to determine an exact value for the power (k) of m. Hence, we analyzed rm for both the m3 and m' models. Figure 4A illustrates an instance for determining rm at -22 mV in the m3 model, and Fig. 4B shows values of rm at various test voltages determined in this myocyte, revealing a voltage-dependence of rm. To quantify such a voltage-dependence of rm, the relation is approximated by the equation: The time constant in a hyperpolarized potential range was assessed by the double pulse protocol (inset in Fig.  4C) , by which the time constants of the deactivation (off kinetics) were determined. Figure 4C and Table 2c(b) show the results from such analyses of the off-kinetics.
Although for rm determinations we used INa data points only after the voltage-settling time to minimize the influence of the membrane-charging process, rm values so determined should still include the error of determina tion. In conclusion, neither dV values that reflect the steepness of the voltage-dependence of the time constant nor Al values of on and off-kinetics appeared to change after taurine exposure.
Rate constant of activation: Using the me data together with the rm data, the rate constants of activation (am and Nm) were determined for the m3 and m' models, according to the empirical equations:
Nm=A EXP(B x Vm) (10) Table 2D shows the results. No parameters changed sig nificantly after taurine addition. Hence, the activation process seems to be relatively insensitive to taurine.
Inactivation kinetics
Steady-state inactivation (h,.): Figure 5 (A-C) illus trates a conventional double pulse method to examine the steady-state inactivation (h.). In 
In Fig. 5D , while taurine shifted Vhalf toward the negative potential direction by 6.8 mV and increased the slope factor by 3.8 mV, the agent essentially did not alter Imax. In total (n=9), taurine significantly increased not only Vhalf, but also slope factor values (Table 3A) . The taurine-induced shift of Vhalf and the taurine induced increase in the slope factor of h. were partially reversed toward the control levels after superfusion with taurine-free solution (Fig. 5: C and D) , indicating that the involvement of the time-related spontaneous shift of kinetic parameters in the hyperpolarizing direction was minor, if any, in the observed negative shifts of Vhalf.
Time constant of inactivation (zh): Decaying time courses after current peaks were approximated by either a single or double exponential function. In most test voltages, the time courses were fitted better by a double rather than a single exponential function (as judged by the F-test or AIC value, see Materials and Methods). In In the presence of taurine, time constants of the fast component decreased by 1.2-0.5 msec at 40 to 20 mV, but not at potentials greater than to 0 mV (data not shown). Similar decreases in the inactivation time con stant (rh) by taurine were also observed when the decaying time courses were fitted by a single exponential function. rh data from the single exponential approximations were Rate constant of inactivation: Using h. and zh data, the rate constants of inactivation (ah and Nh) were calcu lated according to the following equations:
Nh=A/(EXP((Vm+B)/C)+ 1)
and the result is summarized in Table 3B . Values of A and B for the ah equation (eq. 12) and value of C for the Nh equation (eq. 13) were significantly modified by taurine (Table 3B ).
Reproduction of v-c experiments
The combined use of the rate constants of activation (am and ~m, presented in Table 2D ) with those of inacti vation (ah and Nh, presented in Table 3B ) allowed a reproduction of the v-c study (Fig. 6 ). Equations (1), (2), (5) and (6) were used for the reproductions, where m. and zm in eq. (5) and h. and 7h in eq. (6) are given by:
In simulations, GNa/Cm, Cm and Vrev were, respectively, 250 pS/pF, 99 pF and + 59 mV, being in line with the ex perimental results.
In Fig. 6 , values of Vp (ca. -15 mV both in control and taurine) and Imax (ca. 0.7 nA in control, 0.6 nA in taurine) were comparable to those observed experimentally. It is noteworthy that the values of the maximal conductance (GNa) were the same in simulations for the control data and taurine data. In other words, apparent reductions of the peak amplitudes of currents (e.g., Figs. 2 and 6 ) and, in turn, of the conductance (Fig. 3 and Table 1B) in the presence of taurine were derived not from the reduction in the maximal conductance ( GNa) but mainly from changes in the inactivation (h) kinetics with reference to eq. (2). Fig. 6 . Simulated currents to reproduce the single pulse experiment. Top: Superimposed are currents in response to test steps from -60 mV to 0 mV in 5-mV increments and from 0 mV to 60 mV in 10-mV increments, before (A) and after (B) taurine exposures. Bottom: I-V curve. Currents are computed using rate constants of activation (Table 2D ) and inactivation (Table 3B) with eqs. (1), (2), (4) and (5). In the simulations, values for GNa, Cm and VLe, are 250 pS/pF, 99 pF and +59 mV, respectively. The computed-interval is 0.01 msec.
DISCUSSION
Space clamp
In large ventricular cells, it is difficult to maintain a uniform voltage control throughout an experimental period, when compared with small and the spherical myocytes such as embryonic chick cells (10-15 ,um in diameter, < 10 pF) (17). To improve the time resolution and reduce the voltage error at the series resistance, we chose a low temperature (16-17 C), low (80 mM) exter nal Na+, and use of nystatin. The Cm was near 100 pF and the series resistance before compensation was 8.3 MQ. Under 60 70016 R, compensations, experiments were usually carried out with a voltage-settling time of 1 msec or less. We did not use INa data points within that time in analyzing rm. However, such a settling time still must be critical in rm studies.
Magnitude of Na+ current
At a holding potential of -90 mV, the maximal ampli tude of INa (ca.
810 pA/99 pF) was seen at step voltages to near 15 mV. In the present study, the magnitude of currents did not exceed 2 nA at an experimental tempera ture of 17'C. The INa magnitude observed herein was ap parently smaller than those observed in guinea pig ven tricular myocytes (20, 21). The ionic composition of the bath solution in the present study was similar to that in studies of Arita's group (22, 23), in which a rather small amplitude of INa was also observed, and they ascribed it to a possible INa blockade by co-existing divalent cation, Co2+ (22). Actually, Co2+ was shown to alter not only the conductance, but also the activation and inactivation ki netics of the Na+ channel via its screening effects on the surface charge and open channel-blocking actions (24).
We estimated the temperature coefficient (Q10) of the 15 mV, in Table  1B) ; the I-V curves in simulations by the ml model tended to deviate a little from the linear relation between 0 mV and the reversal potential, so as to exhibit a subtle down ward concave function (data not shown). For these rea sons, the simulation data presented in Fig. 6 were in line with the m3 model. This discrepancy may be partly de rived from a poorer space-control in the whole-cell clamp method using patch pipettes, compared to the oil-gap method (21). We recently found, in a theoretical study, that estimations of the power of m is affected by the product, RS x Cm (manuscript in preparation).
Estimation of the maximum conductance
The maximal conductance (GNa) used in the simulation studies was an approximation determined by:
where gNa was the peak conductance at VH (Fig. 3A and Table 1B ); m., rm, and Zh were those at Vp (i.e. 15 mV); TTP was the time to the peak current at Vp; and ho equals h. for VH. Note that the above equation is valid only when both the activation and inactivation start fun ctioning immediately after pulse onset. Accordingly, any delay for activation and inactivation results in, respec tively, an overestimation and underestimation of GNa Table 4 summarizes earlier results of the taurine actions on INa including V.. a, studies carried out on different animal species and tissues or under different experimental conditions, demonstrating diverse actions of taurine on the Na+ channel. Although the reason for such disparities in the experimental results still remains to be elucidated, differences in the experimental method may in part ex plain the disparity in the conclusions. For instance, the distribution and concentration of taurine vary from spe cies to species and from tissue to tissue (1) . Furthermore, the taurine content per se is higher in the endocardium than in the epicardium (8), so that taurine actions might differ even when experiments were done on ventricular cells from the same species. Likewise, ischemia or hy poxia which is encountered during enzymatic cell isola tions is known to reduce intracellular taurine markedly via leakage (8). This also might explain the diverse responses of channels to taurine. Presumed background for the kinetic changes The most noteworthy change in the INa after taurine addition is a reduction in INa magnitude. This is associ ated with a reduction of Na+ conductance (gNa), but not with the maximal conductance (GNa). Furthermore, the reduced gNa seems to be linked largely with the alterations of the inactivation kinetics: a shift of the half inactivation voltage to the negative potential direction and the change in the slope factors of h..
According to the Boltzmann distribution, h. can be expressed as 1 /(1 + EXP(W z • e • d Vm/(k • T))), where W is the voltage-independent energy for opening, z is the number of charges on the gate, e is the elementary charge unit, d is the relative distance across the membrane, k is the Boltzmann constant, and T is the absolute tempera ture (26). The term k . T/e is ca. 24 mV at 16-17 C . The increase in the slope factor for the h. relation from 7 to 11 mV (Table 3A) in the presence of taurine corresponds to either a decrease in the number of movable charges (e) from ca. 3 to 2, reduction of the distance (d) for charges to traverse, or both. A similar change in e and/or d may also be qualitatively the case for the activation kinetics, where the slope factor of m. increased slightly.
In addition to the above taurine-induced restriction of charge movements, a membrane-screening action shared with taurine (a negative shift of Vhalf, Table 3A ) is likely to play an important role in the depressant actions. In the presence of taurine, the hyperpolarizing shifts were larger in extent for the h-parameter than the m-parameter. Such a difference in the extent of the voltage shift of two kinetic parameters, m and h, seems to be occasionally observed, reflecting the difference in the voltage-dependence (27). The mechanisms by which taurine modify channel kinet ics in cardiac tissues are yet unknown. Taurine is known to modify the intracellular Ca" binding of the sarcolem ma (28). At present, we speculate that the taurine-induced changes in the voltage-dependence of Na+ channel kinet ics result from the change in the number of operative Ca ions at the surface of the membrane. On the other hand, taurine per se is strongly negatively-charged at a physio logical pH, and hence, it must be taken into account that the taurine-derived negative charges at the outer mem brane surface can shift the voltage-dependent kinetics. Actually, instances for such changes in the channel kinet ics (negative shifts in the voltage-dependence) induced by organic acids given extracellularly are known (e.g., like those described in Ref. 29). However, since the present v-c experiments were carried out in the presence of 3 mM Cot+, which is also known to alter surface charge (24), taurine actions observed herein could not be simply at tributed to its membrane screening actions.
In conclusion, taurine may stabilize the membrane in such a way that the charge movement for the channel in activation is restricted. Such kinetic changes may result in a reduction of the INa. Whether or not the taurine-induced stabilization of the biological membrane is associated with the well-documented antiarrhythmic effects of this compound (7 10) remains to be clarified. In addition, to improve resolution of the INa, the present study was car ried out at a low temperature. We must be careful in relating the experimental results herein to its clinical effects at the physiological temperature.
